|
Re: potential role of aerobic exercise in modulating cardiotoxic effects of molecular
No bubble popped here. Since Dr Paik's paper showing some her2 "negative" patients incorrectly classified as her2+ in the her2 adjuvant trials did well on herceptin, there have been many theories as to why that occured and even clinical trials to test hypotheses (as you alluded to) Max Wicha's
finding seems the most intriguing to date and the most likely to someday lead to a major change in practice in my opinion.
|